Get the Stockscreener App
0.97
1.04%
0.01
After Hours:
2.58
1.61
+165.98%
Pharmacyte Biotech Inc stock is traded at $0.97, with a volume of 77,097.
It is up +1.04% in the last 24 hours and down -1.96% over the past month.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
See More
Previous Close:
$0.96
Open:
$0.9601
24h Volume:
77,097
Relative Volume:
1.90
Market Cap:
$6.59M
Revenue:
-
Net Income/Loss:
$22.68M
P/E Ratio:
1.8302
EPS:
0.53
Net Cash Flow:
$-1.94M
1W Performance:
+7.79%
1M Performance:
-1.96%
6M Performance:
-44.89%
1Y Performance:
-47.85%
1-Day Range:
$0.92
$1.00
1-Week Range:
$0.8651
$1.13
52-Week Range:
$0.80
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Name
Pharmacyte Biotech Inc
Sector
Industry
Phone
(917) 595.2850
Address
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.53 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1668 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Stock (PMCB) Latest News
PharmaCyte Biotech Inc. Volume Confirms Breakout — Analysts BullishMarket Volume Summary & Capital Efficiency Focused Strategies - thegnnews.com
Is PharmaCyte Biotech Inc. the Top Chart Pick This WeekJuly 2025 Chart Watch & Low Risk High Win Rate Stock Picks - classian.co.kr
Chart overlay techniques for tracking PharmaCyte Biotech Inc.July 2025 Update & Safe Entry Point Alerts - Newser
PharmaCyte Biotech closes $7 million financing to strengthen position - Investing.com
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing | PMCB Stock News - GuruFocus
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - MarketScreener
PharmaCyte Biotech Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Consistent Return Investment Signals - Newser
Is PharmaCyte Biotech Inc. stock ready for a breakout2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Real time scanner hits for PharmaCyte Biotech Inc. explainedDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on PharmaCyte Biotech Inc.2025 Market Trends & High Accuracy Buy Signal Tips - Newser
Can momentum traders help lift PharmaCyte Biotech Inc.July 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Tools to assess PharmaCyte Biotech Inc.’s risk profileJuly 2025 Recap & Accurate Buy Signal Notifications - Newser
Is PharmaCyte Biotech Inc. stock reversal real or fakeJuly 2025 Fed Impact & Low Drawdown Investment Strategies - Newser
Price action breakdown for PharmaCyte Biotech Inc.July 2025 Price Swings & Verified Momentum Stock Alerts - Newser
Will earnings trigger a reversal in PharmaCyte Biotech Inc.July 2025 Setups & Step-by-Step Trade Execution Guides - Newser
PharmaCyte Biotech Inc. Approaches Support With Recovery in SightJuly 2025 Highlights & Free High Accuracy Swing Entry Alerts - beatles.ru
Analyzing PharmaCyte Biotech Inc. with risk reward ratio charts2025 Volatility Report & Low Drawdown Momentum Trade Ideas - Newser
Backtesting results for PharmaCyte Biotech Inc. trading strategiesJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - Newser
PharmaCyte Biotech Raises $7 Million in Private Placement Financing - AInvest
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1.2% – Should You Buy? - Defense World
PharmaCyte Biotech secures $7 million in private placement financing - Investing.com
PharmaCyte Biotech secures $7 million in private placement financing By Investing.com - Investing.com South Africa
PharmaCyte Biotech Secures $7 Million Private Placement - TipRanks
PharmaCyte's $7M Capital Raise: A Calculated Gamble on Shareholder Value? - AInvest
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors | PMCB Stock News - GuruFocus
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Lelezard
PharmaCyte Biotech Raises $7 Million in Capital Financing - AInvest
How high can PharmaCyte Biotech Inc. stock price go in 2025Quarterly Portfolio Report & Consistent Growth Stock Picks - Newser
Is a relief rally coming for PharmaCyte Biotech Inc. holders2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Will PharmaCyte Biotech Inc. stock go up soonWeekly Volume Report & High Yield Equity Trading Tips - Newser
Why PharmaCyte Biotech Inc. stock attracts strong analyst attentionForecast Cut & Safe Capital Allocation Plans - Newser
Can PharmaCyte Biotech Inc. continue delivering strong returnsBreakout Watch & Real-Time Volume Analysis - newsimpact.co.kr
Has PharmaCyte Biotech Inc. found a price floor2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
PharmaCyte Biotech, Inc. announced that it expects to receive $7 million in funding - MarketScreener
How to forecast PharmaCyte Biotech Inc. trends using time seriesPortfolio Risk Summary & Community Driven Trade Alerts - Newser
Pharmacyte Biotech Inc Stock (PMCB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):